- Home
- IBRX vs RNG Comparison
IBRX vs RNG Comparison
Compare IBRX & RNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBRX
- RNG
- Stock Information
- Founded
- IBRX 2014
- RNG 1999
- Country
- IBRX United States
- RNG United States
- Employees
- IBRX N/A
- RNG N/A
- Industry
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- RNG EDP Services
- Sector
- IBRX Health Care
- RNG Technology
- Exchange
- IBRX Nasdaq
- RNG Nasdaq
- Market Cap
- IBRX 2.3B
- RNG 2.8B
- IPO Year
- IBRX N/A
- RNG 2013
- Fundamental
- Price
- IBRX $2.53
- RNG $27.18
- Analyst Decision
- IBRX Strong Buy
- RNG Hold
- Analyst Count
- IBRX 6
- RNG 15
- Target Price
- IBRX $9.83
- RNG $31.79
- AVG Volume (30 Days)
- IBRX 10.3M
- RNG 1.5M
- Earning Date
- IBRX 11-11-2025
- RNG 11-06-2025
- Dividend Yield
- IBRX N/A
- RNG N/A
- EPS Growth
- IBRX N/A
- RNG N/A
- EPS
- IBRX N/A
- RNG N/A
- Revenue
- IBRX $56,600,000.00
- RNG $2,455,731,000.00
- Revenue This Year
- IBRX $629.94
- RNG $5.82
- Revenue Next Year
- IBRX $109.91
- RNG $5.24
- P/E Ratio
- IBRX N/A
- RNG N/A
- Revenue Growth
- IBRX 4227.22
- RNG 6.47
- 52 Week Low
- IBRX $1.83
- RNG $20.59
- 52 Week High
- IBRX $7.48
- RNG $42.19
- Technical
- Relative Strength Index (RSI)
- IBRX 47.77
- RNG 35.55
- Support Level
- IBRX $2.42
- RNG $27.76
- Resistance Level
- IBRX $2.75
- RNG $28.80
- Average True Range (ATR)
- IBRX 0.13
- RNG 1.10
- MACD
- IBRX -0.01
- RNG -0.45
- Stochastic Oscillator
- IBRX 22.88
- RNG 1.67
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.
About RNG RingCentral Inc.
RingCentral is a unified communications as a service, or UCaaS, provider. Its software helps users communicate and collaborate via voice, video, and messaging across all device types and all from one platform. RingCentral helps customers modernize and move from legacy on-premises systems to modern, cloud-based systems. Beyond its core RingCentral MVP solution, RingCentral also offers a cloud-based contact center solution, a stand-alone video meetings solution, and webinars.